Synthesis, antidiabetic activity and molecular docking studies of novel aryl benzylidenethiazolidine-2,4-dione based 1,2,3-triazoles

IF 3.9 2区 化学 Q2 CHEMISTRY, APPLIED
Nagesh Patnam, Kishan Chevula, Prasad Chennamsetti, Balaswamy Aleti, Aruna Kumari Kotha, Vijjulatha Manga
{"title":"Synthesis, antidiabetic activity and molecular docking studies of novel aryl benzylidenethiazolidine-2,4-dione based 1,2,3-triazoles","authors":"Nagesh Patnam,&nbsp;Kishan Chevula,&nbsp;Prasad Chennamsetti,&nbsp;Balaswamy Aleti,&nbsp;Aruna Kumari Kotha,&nbsp;Vijjulatha Manga","doi":"10.1007/s11030-023-10674-y","DOIUrl":null,"url":null,"abstract":"<p>A series of novel aryl benzylidenethiazolidine-2,4-dione based 1,2,3-triazoles synthesized in a straightforward route consisting of benzylidenethiazolidine-2,4-dione and 1,2,3-triazole pharmacophores. The new scaffolds tested for in vitro antidiabetic activity by inhibition of aldose reductase enzyme and its inhibition measured in half of Inhibition Concentration (IC<sub>50</sub>). The activity results correlated with standard reference <i>Sorbinil</i> (IC<sub>50</sub>: 3.45 ± 0.25 µM). Among all the titled compounds <b>8f</b> (1.42 ± 0.21 µM), <b>8d</b> (1.85 ± 0.39 µM), <b>13a</b> (1.94 ± 0.27 µM) and <b>8b</b> (1.98 ± 0.58 µM) shown potent activity. In addition, molecular docking results against the crystal structure of aldose reductase (PDB ID: 1PWM) revealed that the binding affinities shown by all synthesized compounds are higher than the reference compound <i>Sorbinil.</i> The docking scores, H-bond interactions, and hydrophobic interactions well defined inhibition strength of all compounds.\n</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":"28 3","pages":"1551 - 1563"},"PeriodicalIF":3.9000,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Diversity","FirstCategoryId":"92","ListUrlMain":"https://link.springer.com/article/10.1007/s11030-023-10674-y","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0

Abstract

A series of novel aryl benzylidenethiazolidine-2,4-dione based 1,2,3-triazoles synthesized in a straightforward route consisting of benzylidenethiazolidine-2,4-dione and 1,2,3-triazole pharmacophores. The new scaffolds tested for in vitro antidiabetic activity by inhibition of aldose reductase enzyme and its inhibition measured in half of Inhibition Concentration (IC50). The activity results correlated with standard reference Sorbinil (IC50: 3.45 ± 0.25 µM). Among all the titled compounds 8f (1.42 ± 0.21 µM), 8d (1.85 ± 0.39 µM), 13a (1.94 ± 0.27 µM) and 8b (1.98 ± 0.58 µM) shown potent activity. In addition, molecular docking results against the crystal structure of aldose reductase (PDB ID: 1PWM) revealed that the binding affinities shown by all synthesized compounds are higher than the reference compound Sorbinil. The docking scores, H-bond interactions, and hydrophobic interactions well defined inhibition strength of all compounds.

Abstract Image

新型芳基亚苄基噻唑烷-2,4-二酮基 1,2,3-三唑的合成、抗糖尿病活性和分子对接研究。
以苄基亚噻唑烷-2,4-二酮和 1,2,3- 三唑药基为基础,通过简单的方法合成了一系列新型芳基苄基亚噻唑烷-2,4-二酮基 1,2,3- 三唑。新支架通过抑制醛糖还原酶进行了体外抗糖尿病活性测试,其抑制作用以抑制浓度的一半(IC50)来衡量。活性结果与标准参考物索比尼尔(IC50:3.45 ± 0.25 µM)相关。在所有标题化合物中,8f(1.42 ± 0.21 µM)、8d(1.85 ± 0.39 µM)、13a(1.94 ± 0.27 µM)和 8b(1.98 ± 0.58 µM)显示出强大的活性。此外,与醛糖还原酶晶体结构(PDB ID:1PWM)的分子对接结果显示,所有合成化合物的结合亲和力均高于参考化合物索比尼尔。对接得分、氢键相互作用和疏水相互作用很好地确定了所有化合物的抑制强度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Diversity
Molecular Diversity 化学-化学综合
CiteScore
7.30
自引率
7.90%
发文量
219
审稿时长
2.7 months
期刊介绍: Molecular Diversity is a new publication forum for the rapid publication of refereed papers dedicated to describing the development, application and theory of molecular diversity and combinatorial chemistry in basic and applied research and drug discovery. The journal publishes both short and full papers, perspectives, news and reviews dealing with all aspects of the generation of molecular diversity, application of diversity for screening against alternative targets of all types (biological, biophysical, technological), analysis of results obtained and their application in various scientific disciplines/approaches including: combinatorial chemistry and parallel synthesis; small molecule libraries; microwave synthesis; flow synthesis; fluorous synthesis; diversity oriented synthesis (DOS); nanoreactors; click chemistry; multiplex technologies; fragment- and ligand-based design; structure/function/SAR; computational chemistry and molecular design; chemoinformatics; screening techniques and screening interfaces; analytical and purification methods; robotics, automation and miniaturization; targeted libraries; display libraries; peptides and peptoids; proteins; oligonucleotides; carbohydrates; natural diversity; new methods of library formulation and deconvolution; directed evolution, origin of life and recombination; search techniques, landscapes, random chemistry and more;
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信